Anxiety
-
Healthy habits around diet and exercise are a good idea at any time, but a new study has emphasized the importance of forming them early in life, demonstrating in mice that they can lead to increased brain mass and lower levels of anxiety as adults.
-
For some people a small irritation can wreck their day, while others can shake off minor problems and move on. A new study is suggesting persistent activity in the amygdala could be why some are unable to move on from momentary negative experiences.
-
How often do you clear out old photos on your phone or tidy up your email inbox? You just may be a digital hoarder, and researchers from Northumbria University have identified four distinct types.
-
Australian scientists have developed a world-first test claimed to accurately measure levels of a brain protein associated with depression and bipolar disorder. The test could offer doctors an objective diagnostic tool to assess patients.
-
In the largest and longest follow-up study to date investigating the lingering effects of COVID-19, researchers have found more than two-thirds of hospitalized patients report at least one ongoing symptom six months after contracting the disease.
-
Research has suggested that anxiety is an early indicator for Alzheimer's disease, which often follows mild cognitive decline (MCI). A new study has now found a link between anxiety and an increased rate of progression from MCI to Alzheimer's disease.
-
Researchers have discovered a set of neurons in the mouse brain that appear to control physiological responses to fear, like heart palpitations and pupil dilations. Tests in mice suggest this region could be a new drug target for anxiety treatments.
-
A new analysis of US patient data has found nearly one in five people are diagnosed with a psychiatric illness within three months of a positive COVID-19 test. The study suggests recovered patients are twice as likely to suffer from anxiety or depression.
-
Four terminally ill cancer patients in Canada have been granted a special exemption to legally possess and consume psilocybin. They are the first in the country, outside a clinical trial, allowed to do so since the psychedelic was made illegal in 1974.
-
A new review is suggesting psilocybin may have great potential as a treatment for OCD. The review sums up the current evidence arguing psychedelic therapy should be effective for OCD in the same way it has shown efficacy treating depression and anxiety.
-
Neuroscientists from the University of Cambridge have identified apathy as an important early sign of dementia. The research finds apathy is distinct from depression, and offers a more accurate longitudinal association with the onset of dementia.
-
A new study has solved a long-standing mystery of how acute stress seems to amplify inflammatory disease, despite the fact many stress hormones actually suppress the immune system. It found a specific immune cell is released by fat cells when stressed.